Platinum Room 7 - IX Investor 08
Friday, 26 September,, ExCeL London
Introduction by Andy Hartwill, Head of Research, Objective Capital
Objective Capital, in association with The Information Exchange, will be presenting the second small Cap Investors Forum, featuring a number of small cap growth companies, in the Platinum Suite at the EXCel Centre, Docklands, London on Friday 26th September. It will form part of the IX Investors 08 Exhibition.
The programme for the Forum has been designed to present a wide variety of exciting growth companies to delegates and give those attending plenty of opportunity to join in a "Question Time" style session following each session. There will also be an opportunity to meet the speakers, all of who are senior directors of the companies presenting. Each speaker has 15 minutes to tell us about their company. There will be 3 companies presenting each one-hour session, so the pace will be fast, giving the audience the maximum exposure to some of the most interesting growth companies on the markets.
This really is a fantastic opportunity to really learn a lot about these companies, and their industry sectors, in a fairly short space of time. Register now and come along to Docklands on Friday 26th September and meet the companies.
For further details, contact:
Iain McWhirter
+44-20-7073 2691
iain@objectivecapital.com
Read below about the companies that took part in our last event on 20th June 2008...
Objective Capital – Andy Hartwill
http://www.objectivecapital.com Andy has over 20 years of experience in financial markets. After a successful career as an engineer, specialising in space and communications technologies, he spent several years in venture capital. He moved to the quoted sector and has since held positions on both sides of the “fence” including Head of Equities for Capital House (fund management), UK and European Strategist for Paribas and then Societe Generale. Before joining Objective Capital he was Global Strategist for SG Hambros advising on the construction of investment portfolios. Andy is a regular guest on Bloomberg and CNBC.
Accura
http://www.accurapharma.com Accura Animal Health Diagnostics has novel diagnostic products in the fields of research animal quality screening and mastitis detection in dairy cows. The group has developed products that are at market and generating revenue in over 40 countries globally. The products are stable, proven, and poised for significant growth. Accura Animal Health Pharmaceuticals is focused on developing pharmaceuticals for the companion animal market sourced from university-based or boutique biotech innovation. Bernard Ross – CEO Bernard has over 15 years of senior experience at private and public board level across multiple industries including pharmaceutical, technology development and FMCG. A former Head of International Development at CMI plc, Senior Vice President, Cardiovascular of Bioaccelerate Inc. (NASDAQ: BACL) and CEO of Inncardio Inc. (NASDAQ: INDO).
AG Technologies
http://www.argent47.com AG Technologies, a science and technology company focused on curtailing the spread of infection, has developed the only proven technology to bond pure silver to fabric. This innovative and proprietary technology is 99.99% effective to prevent the spread of bacteria, staph, E. coli and MRSA. The technology is available for a wide range of industries and companies that are seeking a way to mitigate the risk destructive agents cause. Michael Indiano – Founder and CEO In 2000, Michael Indiano, a textile industry executive with 40 experience, set out to develop a natural defence against bacteria, with the use of innovative technology. Working with some of the best scientific experts in their field and creating a proprietary manufacturing process, Mr Indiano and his team created the breakthrough silver bonded fabric that is the basis of all Argent 47 products. These products are renowned for their purity and effectiveness in reducing the risk of bacterial infection.
Colt Resources
http://www.coltresources.com Colt Resources is a Canadian company based in Vancouver, engaged in the acquisition and exploration of mineral properties. Colt commenced trading on the Canadian Trading and Quotation System (CNQ) in March 2007, Symbol: COLT. The company is currently engaged in the exploration of 4 properties: Penedono Gold Property (Portugal); Armamar Meda Base Metals Property (Portugal); Extra High Property (British Columbia); Uranium Properties (Quebec). Bedo Kalpakian – President & CEO Bedo Kalpakian serves as chief executive officer and president of Colt Resources. He has also been chief financial officer of LasVegasFromHome.com Entertainment Inc. since mid-2007 and has been its chairman since 1991. He has been the president of ZAB Resources Inc, formerly Bronx Ventures Inc and Lucky 1 Enterprises Inc, since 1991 and serves as its chief executive officer and chief financial officer. Mr Kalpakian is also the president and chief executive officer of Mountain Capital Inc and the chief financial officer and of Touchdown Capital Inc. Mr Kalpakian holds a Full Technological Certificate from the City & Guilds of London Institute.
The China Food Company
http://www.chinafoodcompany.com The China Food Company plc (CFC) is a leading producer of Animal Feed (Fuss Feed) and Consumer Condiments (Fu-Rich) with operations located in the PRC’s province of Shandong. Fuss Feed commenced trading in 1994 as a manufacture of Compound Feed for poultry, cows and pigs; it has since diversified to manufacture higher margin Premix and Concentrate Feed, operating two production lines at a 15,000 sq.m. plant in Shou Guang City, Shandong. In August 2001, Fu-Rich began trading as a producer and seller of a range of condiments, primary of different types of soya source, vinegar and bean paste under its own brand names. In addition to its own products, it also sells other food products, for example, pickled products, fungi products, chilli oil and other flavour-enhancers that are sourced from third party manufacturers and resold under its own brand names. John McLean – Non Executive Chairman John McLean is Chairman of Albany Capital plc, which he co-founded in 2006 to invest in pre- IPO and other investments. He is also the Chief Executive Officer of Fairfax Classical Properties Limited, a company that he co-founded in 2003, which builds deluxe houses in the South of England. John has had extensive business experience in a variety of sectors, including retail, branded products, property investment and development, textiles, mobile telephony, cable TV, manufacturing, licensing and logistics. He has managed operations globally, with specific expertise in China, Australia, the USA, Canada and Europe. John has a long track record in the development of growing companies and has operated as both managing director and finance director. John is a Chartered Accountant and was formerly with Coopers & Lybrand in both London and New York.
Epistem
http://www.epistem.co.uk Epistem is a biotechnology company commercialising adult stem cells in the areas of oncology and gastrointestinal diseases as well as cosmeceutical applications. Epistem develops innovative therapeutics and diagnostic biomarkers and provides contract research services to drug development companies. The Group’s expertise is focused on the regulation of adult stem cells located in epithelial tissue, which includes the gastrointestinal tract, skin, hair follicles, breast and prostate. Matthew Walls – CEO Matthew joined Epistem in February 2007 as Chief Executive Officer. Matthew is an experienced CEO most recently with Oxford BioSignals Limited where he led the strategic ‘diagnostic’ collaboration with Rolls Royce Plc and Covance Inc and completed the recent fundraising and repositioning of the medical diagnostic business to the United States. Matthew spent the early part of his career with ICI plc before moving to head up the corporate financial and commercial development of plant biotechnology at AstraZeneca plc prior to its merger with Novartis to form Syngenta plc.
Peat Resources
http://www.peatresources.com Peat Resources Limited, an Ontario company, has developed a wet mining process, using conventional equipment, to produce peat fuel. The process starts with wet mining of raw peat. A proprietary upgrading step is followed by mechanical dewatering to 40% solids (by weight) through a continuous high-pressure press. The dewatered peat is then dried thermally to the desired moisture content to achieve a density comparable to coal. PeterG.Telford,B.Sc.,Ph.D.–PresidentandCEO,Director Former manager of Ontario peat resource inventory (Energy Resources Program, Ontario Geological Survey) and held senior positions with the Ministries of Natural Resources, Northern Development and Mines, Environment and Energy. He is an international consultant on energy and climate change issues.
Plethora Solutions
http://www.plethorasolutions.co.uk Plethora Solutions (AIM: PLE) is a fast growing London, (UK)-based company created in 2003 to develop new treatments for urological disorders affecting both men and women. In the last four years, Plethora Solutions has built a well-balanced product portfolio, targeting male sexual health, urinary incontinence and women’s health. Three marketed products, ErecAid®, RigiScan® and Acticuf®, are distributed through its Timm Medical Inc specialist sales force in the USA. Two major products in Phase III are expected to reach the market around the end of 2009 and another four products are in late Phase II clinical development. Plethora is in a strong position to become a fully integrated profitable pharmaceutical company within the next two years. Dr Steven Powell – CEO Steven Powell joined Plethora as CEO in 2004. Prior to this he was a director of the Gilde Biotechnology and Nutrition Fund, a pan-European venture capital fund focused on investments in early-stage companies. Steven has 20 years of experience in the pharmaceutical and life sciences sector, latterly as CEO of UK quoted biopharmaceutical company, KS Biomedix plc, until its acquisition by Xenova. He has worked in research and development, commercial and general management roles, initially for Beecham Pharmaceuticals (GSK) and subsequently with Whatman, Chiroscience, Celsis and Active Biotech. Steven has also helped to establish and finance a number of small life science businesses in a non-executive role.
Columbia Yukon Explorations
http://www.columbiayukon.com Columbia Yukon Explorations is a mineral exploration company. Its most advanced property is the Storie molybdenum deposit located near the historic mining camp of Cassiar, B.C. The Storie deposit has a NI 43-101 compliant inferred mineral resource of 101.6 M/tonnes grading 0.067% Mo or 0.112% MoS2. With a senior management team well versed in financing and exploration, a superior technical Advisory Board and a well funded treasury, CYU is positioned to maximise the value of the Storie and other projects to create value for its shareholders. Ted Ohashi – CFA With an MBA from the University of British Columbia (1969) and qualified as a Chartered Financial Analyst and a Fellow of Financial Analysts Society Ted began working life as a portfolio manager and an investment advisor. He has been a President of a mutual fund management company, Partner in a financial planning firm, President and founder of a Vancouver based securities firm and managed a small cap mutual fund between1996-1999. He is now an investment and corporate communications consultant to Columbia Yukon Explorations. He is a regular speaker at conferences (inc. the Canadian Pension Fund Conference, International Gold Conference, Agency for International Development (Washington, D.C.)). He is widely published in the financial press and has hosted the television program “Opening Doors on the Knowledge Network”. Stefan Wozniak – Senior Engineer Stefan has a Bachelors of Applied Science in Mining Engineering from the University of British Columbia. After graduation, he worked with Phelps Dodge as a metallurgist at Chino, a copper-moly deposit in New Mexico. Stefan also has operating experience with Huckleberry Mines, Highland Valley Copper, North American Palladium as well as with Cochrane Engineering where he worked on the engineering design of the Wolverine washing plant in Tumbler Ridge. He also has hands-on experience with junior mining companies including Global Hunter Copper and Majestic Gold as the in-house engineer.
Great Western Minerals
http://www.gwmg.ca Great Western Minerals is Saskatchewan- based, vertically integrated mining through to engineering business, specialising in the extraction of rare earth minerals and applying their unique properties to high technology and industrial applications. Over the past decade major rare earth mining facilities in North America have closed, largely due to environmental concerns and competition from China. Given their application in areas of strategic importance, attention is refocusing on the need to establish alternatives to the current Chinese dominance. Great Western Minerals aims to be in the vanguard of such moves. Through a Mines-to-Market strategy GWMR at one end of this strategic spectrum, explores for, and will ultimately develop, properties to supply rare earth elements (REE) for its own use, as well as to other end users who currently rely solely on foreign sources. At the other end of the spectrum, through its wholly owned subsidiary, Great Western Technologies Inc (GWTI), the Company has the proven capability to create value added products for blue-chip, global end users in the aerospace, automotive, industrial and high-technology sectors. James B. Engdahl – President & CEO, Director Jim has 20 years of experience in corporate finance at the executive level and extensive expertise in financing mergers, acquisitions, and reorganizations. A former VP of Barclays Bank of Canada, Jim has served as President, CEO, and director of Pacific & Western Trust, President and Director of Shore Gold Inc., and VP of Finance and Director of Claude Resources Inc. More recently, he was the Regional Advisory Partner of the corporate finance arm of one of Western Canada’s largest accounting firms. Jim was intimately involved in financing two producing gold mines in Saskatchewan. He currently sits on the Board of Directors of Formation Capital Inc., a TSE-listed company currently bringing a cobalt/copper mine into production in the United States. Jim’s expertise will enable GWMG to wisely manage its Hoidas Lake rare earth project to feasibility level and develop a market niche with Great Western Technologies Inc.
SOFAME Technologies
http://www.sofame.com Sofame custom engineers and manufactures unique, high-efficiency direct-contact heat recovery and hot water heating systems. Sofame’s products extract up to 99% of heat from flue gases depending on the application, and also from wastewater, and return the energy in the form of high temperature hot water or preheated make-up air. In addition to economically recovering heat from waste energy, Sofame’s products also help customers to significantly reduce greenhouse gas emissions. Using world leading patented green technology, the company serves building owners, institutional, industrial and commercial markets through a network of dedicated engineering representatives. Jérôme Cliché – Corporate Advisor
York Pharma
http://www.yorkpharma.com York Pharma plc is a pharmaceutical group, established in 2003, which will market and supply branded prescription products to pharmaceutical wholesalers, hospitals and general practitioners within the field of dermatology. The Group currently has at its disposal more than 20 patent families (with over 100 individual patents/patent applications) and intellectual property in relation to its portfolio of novel dermatology products and technology platforms in the key therapeutic areas of fungal infection, eczema/dermatitis, psoriasis, vitiligo and acne. Speaker – t/b/d
